{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:07:52Z","timestamp":1790485672227,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bpa.2020.08.002","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T21:10:53Z","timestamp":1596834653000},"page":"383-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacological options for the treatment of chronic migraine pain"],"prefix":"10.1016","volume":"34","author":[{"given":"Ivan","family":"Urits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Charipova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec M.","family":"Zamarripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lassiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/2049463712459691","article-title":"Headache disorders: differentiating and managing the common subtypes","volume":"6","author":"Ahmed","year":"2012","journal-title":"Br J Pain"},{"issue":"10053","key":"10.1016\/j.bpa.2020.08.002_bib2","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Vos","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bpa.2020.08.002_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1416","article-title":"Chronic migraine","volume":"348","author":"Schwedt","year":"2014","journal-title":"Br Med J"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib4","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1468-2982.2008.01811.x","article-title":"Is chronic migraine one end of a spectrum of migraine or a separate entity?","volume":"29","author":"Aurora","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bpa.2020.08.002_bib5","first-page":"1315","volume":"vol. 391","author":"Dodick","year":"2018"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/head.12999","article-title":"Chronic migraine: an update on physiology, imaging, and the mechanism of action of two available pharmacologic therapies","volume":"57","author":"Aurora","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.bpa.2020.08.002_bib7","series-title":"Neurological sciences","first-page":"147","article-title":"Polytherapy for migraine prophylaxis","author":"Casucci","year":"2012"},{"key":"10.1016\/j.bpa.2020.08.002_bib8","series-title":"Expert opinion on drug metabolism and toxicology","first-page":"399","article-title":"Choosing the safest acute therapy during chronic migraine prophylactic treatment: pharmacokinetic and pharmacodynamic considerations","volume":"12","author":"Lionetto","year":"2016"},{"key":"10.1016\/j.bpa.2020.08.002_bib9","series-title":"Efficacy and mechanism of anticonvulsant drugs in migraine","first-page":"191","volume":"7","author":"Hoffmann","year":"2014"},{"issue":"Suppl 1","key":"10.1016\/j.bpa.2020.08.002_bib10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/S031716710003482X","article-title":"Topiramate: pharmacokinetics and pharmacodynamics","volume":"25","author":"Sehneiderman","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.bpa.2020.08.002_bib12","series-title":"Current pain and headache reports","article-title":"A\u00a0comprehensive review of over-the-counter treatment for chronic migraine headaches","volume":"24","author":"Peck","year":"2020"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/14756360701507001","article-title":"Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate","volume":"23","author":"Shank","year":"2008","journal-title":"J\u00a0Enzym Inhib Med Chem"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/0271678X17729280","article-title":"Targeting the central projection of the dural trigeminovascular system for migraine prophylaxis","volume":"39","author":"Akerman","year":"2019","journal-title":"J\u00a0Cerebr Blood Flow Metabol"},{"issue":"13","key":"10.1016\/j.bpa.2020.08.002_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1177\/0333102411418259","article-title":"Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway","volume":"31","author":"Andreou","year":"2011","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.bpa.2020.08.002_bib16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1468-2982.2004.00767.x","article-title":"Topiramate inhibits trigeminovascular neurons in the cat","volume":"24","author":"Storer","year":"2004","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.bpa.2020.08.002_bib17","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-2982.2008.01682.x","article-title":"Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine","volume":"28","author":"Martella","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bpa.2020.08.002_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-8993(85)90717-6","article-title":"Inhibitory influence of GABA on central serotonergic transmission. Involvement of the habenulo-raph\u00e9 pathways in the GABAergic inhibition of ascending cerebral serotonergic neurons","volume":"331","author":"Nishikawa","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.bpa.2020.08.002_bib20","unstructured":"Cutrer FM, Silberstein SD, Mathew NT, et\u00a0al. Antiepileptic drugs in migraine, cluster headache, and mood disorders."},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-016-0631-z","article-title":"Valproate ameliorates nitroglycerin-induced migraine in trigeminal nucleus caudalis in rats through inhibition of NF-\u043aB","volume":"17","author":"Li","year":"2016","journal-title":"J\u00a0Headache Pain"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib22","first-page":"277","article-title":"Effects of pregabalin on central sensitization in patients with migraine","volume":"53","author":"Zhang","year":"2015","journal-title":"Int J Clin Pharm Ther"},{"key":"10.1016\/j.bpa.2020.08.002_bib23","series-title":"Gabapentin: a Ca2+ channel \u03b12-\u03b4 ligand far beyond epilepsy therapy","first-page":"353","volume":"vol. 44","author":"Striano","year":"2008"},{"key":"10.1016\/j.bpa.2020.08.002_bib24","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-019-0774-0","article-title":"Membrane stabilizer medications in the treatment of chronic neuropathic pain: a comprehensive review","volume":"23","author":"Viswanath","year":"2019","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bjp.0705246","article-title":"A\u00a0comparison of Ca 2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices","volume":"139","author":"Oka","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bpa.2020.08.002_bib26","series-title":"Pharmaceutica acta helvetiae","first-page":"163","article-title":"Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics","author":"Hieble","year":"2000"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bpa.2020.08.002_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11916-004-0022-z","article-title":"Prophylactic migraine therapy: mechanisms and evidence","volume":"8","author":"Ramadan","year":"2004","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.002_bib29","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1097\/j.pain.0000000000001007","article-title":"Propranolol treatment prevents chronic central sensitization induced by repeated dural stimulation","volume":"158","author":"Boyer","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bpa.2020.08.002_bib30","series-title":"Current treatment options in neurology","article-title":"Beta-blockers for migraine prevention: a review article","volume":"21","author":"Danesh","year":"2019"},{"key":"10.1016\/j.bpa.2020.08.002_bib31","series-title":"Progress in drug research","first-page":"219","article-title":"Serotonin in migraine: theories, animal models and emerging therapies","volume":"51","author":"Johnson","year":"1998"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13311-018-0621-8","article-title":"Current prophylactic medications for migraine and their potential mechanisms of action","volume":"15","author":"Sprenger","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.bpa.2020.08.002_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/123.9.1830","article-title":"Nitric oxide-induced headache in patients with chronic tension-type headache","volume":"123","author":"Ashina","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.bpa.2020.08.002_bib34","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S1388-2457(03)00024-5","article-title":"Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance","volume":"114","author":"Schoenen","year":"2003","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.410250204","article-title":"Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials","volume":"25","author":"Diener","year":"1989","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.002_bib36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"issue":"S1","key":"10.1016\/j.bpa.2020.08.002_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10072-015-2195-0","article-title":"Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine","volume":"36","author":"Barbanti","year":"2015","journal-title":"Neurol Sci"},{"key":"10.1016\/j.bpa.2020.08.002_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejphar.2016.09.019","article-title":"Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain","volume":"791","author":"Zychowska","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bpa.2020.08.002_bib39","series-title":"Acta neurologica scandinavica","first-page":"442","article-title":"Botulinum toxin: a review of the mode of action in migraine","volume":"137","author":"Do","year":"2018"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00702-013-1150-6","article-title":"Association of antinociceptive action of botulinum toxin type A with GABA-A receptor","volume":"121","author":"Drinovac","year":"2014","journal-title":"J\u00a0Neural Transm"},{"issue":"12","key":"10.1016\/j.bpa.2020.08.002_bib41","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00702-016-1605-7","article-title":"Antinociceptive action of botulinum toxin type A in carrageenan-induced mirror pain","volume":"123","author":"Drinovac Vlah","year":"2016","journal-title":"J\u00a0Neural Transm"},{"key":"10.1016\/j.bpa.2020.08.002_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pneurobio.2009.07.005","article-title":"Pathophysiological basis of migraine prophylaxis","volume":"89","author":"Galletti","year":"2009","journal-title":"Prog Neurobiol"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/138161206775474503","article-title":"L-type calcium channels","volume":"12","author":"Triggle","year":"2006","journal-title":"Curr Pharmaceut Des"},{"issue":"5 SUPPL. 1","key":"10.1016\/j.bpa.2020.08.002_bib44","article-title":"Verapamil and migraine prophylaxis: mechanisms and efficacy","volume":"90","author":"Markley","year":"1991","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-2999(00)00897-9","article-title":"Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility","volume":"411","author":"Ruiz-Nuo","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0019-5049.63652","article-title":"L-type calcium channel blockers, morphine and pain: newer insights","volume":"54","author":"Kumar","year":"2010","journal-title":"Indian J Anaesth"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib47","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1213\/01.ANE.0000184253.49849.B0","article-title":"Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance","volume":"101","author":"Dogrul","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bpa.2020.08.002_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/164_2019_336","article-title":"Ion channel pharmacology for pain modulation","volume":"260","author":"De Logu","year":"2019","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10194-011-0300-1","article-title":"Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions","volume":"12","author":"Li","year":"2011","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.bpa.2020.08.002_bib50","first-page":"1293","volume":"27","author":"Hamel","year":"2007"},{"key":"10.1016\/j.bpa.2020.08.002_bib51","article-title":"Off-label antidepressant use for treatment and management of chronic pain: evolving understanding and comprehensive review","volume":"23","author":"Urits","year":"2019","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1254\/jjp.82.130","article-title":"Antinociception induced by amitriptyline and imipramine is mediated by \u03b1(2A)-adrenoceptors","volume":"82","author":"Ghelardini","year":"2000","journal-title":"Jpn J Pharmacol"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib53","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ana.20778","article-title":"Suppression of cortical spreading depression in migraine prophylaxis","volume":"59","author":"Ayata","year":"2006","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0168-0102(97)00072-2","article-title":"Effects of tricyclic and tetracyclic antidepressants on the three subtypes of GABA transporter","volume":"29","author":"Nakashita","year":"1997","journal-title":"Neurosci Res"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.002_bib55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1468-2982.2003.00526.x","article-title":"Selective decrease in serotonin synthesis rate in rat brainstem raphe nuclei following chronic administration of low doses of amitriptyline: an effect compatible with an anti-migraine effect","volume":"23","author":"Pringsheim","year":"2003","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib56","first-page":"154","article-title":"Effect of NOS3 gene polymorphism on response to Tricyclic antidepressants in migraine attacks","volume":"13","author":"Molana","year":"2014","journal-title":"Iran J Neurol"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1586\/14737175.9.3.369","article-title":"Role of magnesium in the pathogenesis and treatment of migraine","volume":"9","author":"Sun-Edelstein","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.bpa.2020.08.002_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0022-510X(95)00196-1","article-title":"Mitochondria, magnesium and migraine","volume":"134","author":"Welch","year":"1995","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0361-9230(01)00440-3","article-title":"Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache","volume":"54","author":"Lodi","year":"2001","journal-title":"Brain Res Bull"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.002_bib60","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.58.8.1227","article-title":"Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes","volume":"58","author":"Boska","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.bpa.2020.08.002_bib61","first-page":"888","article-title":"Menstrually related migraine: breaking the cycle in your clinical practice","volume":"52","author":"Silberstein","year":"2007","journal-title":"J\u00a0Reprod Med Obstetrician Gynecologist"},{"issue":"Suppl 2","key":"10.1016\/j.bpa.2020.08.002_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/head.13081","article-title":"The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine","volume":"57","author":"Edvinsson","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.bpa.2020.08.002_bib63","series-title":"An evidence-based review of fremanezumab for the treatment of migraine","author":"Urits","year":"2020"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.002_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11916-019-0768-y","article-title":"CGRP antagonists for the treatment of chronic migraines: a comprehensive review","volume":"23","author":"Urits","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.bpa.2020.08.002_bib65","first-page":"659","volume":"59","author":"Iyengar","year":"2019"},{"key":"10.1016\/j.bpa.2020.08.002_bib66","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Clinical reviews in allergy and immunology Histamine and H 1-antihistamines: celebrating a century of progress","volume":"128","author":"Leung","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/head.13164","article-title":"Histamine and migraine","volume":"58","author":"Yuan","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.bpa.2020.08.002_bib68","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/head.12293","article-title":"Histamine in migraine and brain","volume":"54","author":"Alstadhaug","year":"2014","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib69","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s10194-019-0984-1","article-title":"Histamine and migraine revisited: mechanisms and possible drug targets","volume":"20","author":"Worm","year":"2019","journal-title":"J\u00a0Headache Pain"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212785","article-title":"Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis","volume":"14","author":"Jackson","year":"2019","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003225.pub2","article-title":"Propranolol for migraine prophylaxis","author":"Linde","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.002_bib72","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","article-title":"Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention","volume":"87","author":"Gon\u00e7alves","year":"2016","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clineuro.2004.03.004","article-title":"Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study","volume":"107","author":"Bulut","year":"2004","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.002_bib74","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.clineuro.2008.05.025","article-title":"A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine","volume":"110","author":"Keskinbora","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib75","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.clinthera.2009.03.020","article-title":"Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs","volume":"31","author":"Dodick","year":"2009","journal-title":"Clin Therapeut"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.002_bib76","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1503\/cmaj.081657","article-title":"Prophylaxis of migraine headache","volume":"182","author":"Pringsheim","year":"2010","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib77","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/WNF.0000000000000280","article-title":"Comparing the effects of atorvastatin with sodium valproate (divalproex) on frequency and intensity of frequent migraine headaches: a double-blind randomized controlled study","volume":"41","author":"Hesami","year":"2018","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib78","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib79","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2020.01.031","article-title":"Medications approved for preventing migraine headaches","volume":"133","author":"Spindler","year":"2020","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.002_bib80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1526-4610.1989.hed2907425.x","article-title":"Verapamil in migraine prophylaxis - A five-year review","volume":"29","author":"Solomon","year":"1989","journal-title":"Headache J Head Face Pain"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib81","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.a.30323","article-title":"Mitochondrial DNA control region sequence variation in Migraine headache and cyclic vomiting syndrome","volume":"131","author":"Wang","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.bpa.2020.08.002_bib82","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jcpt.12548","article-title":"Prophylaxis of migraine headaches with riboflavin: a systematic review","volume":"42","author":"Thompson","year":"2017","journal-title":"J\u00a0Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib83","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ajcn\/63.1.54","article-title":"Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans","volume":"63","author":"Zempleni","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bpa.2020.08.002_bib84","series-title":"Gabapentin in headache disorders: what is the evidence?","first-page":"162","volume":"17","author":"Perloff","year":"2016"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib85","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/head.12781","article-title":"The use of antiepileptics in migraine prophylaxis","volume":"56","author":"Bagnato","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.bpa.2020.08.002_bib86","series-title":"Current treatment options in neurology","article-title":"Current status of antiepileptic drugs as preventive migraine therapy","volume":"21","author":"Parikh","year":"2019"},{"key":"10.1016\/j.bpa.2020.08.002_bib87","series-title":"Cochrane database of systematic reviews","article-title":"Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults","volume":"2013","author":"Linde","year":"2013"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib88","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0895-7061(99)00250-2","article-title":"Newly emerging pharmacologic differences in angiotensin II receptor blockers","volume":"13","author":"Oparil","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.bpa.2020.08.002_bib89","series-title":"The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis","first-page":"1043","volume":"14","author":"Ripa","year":"2014"},{"key":"10.1016\/j.bpa.2020.08.002_bib90","first-page":"263","volume":"vol. 22","author":"Gleiter","year":"2004"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.002_bib91","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1526-4610.2004.04148.x","article-title":"Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study","volume":"44","author":"Smuts","year":"2004","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib92","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00006534-200008000-00030","article-title":"Corrugator supercilii muscle resection and migraine headaches","volume":"106","author":"Guyuron","year":"2000","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","article-title":"Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy","volume":"44","author":"Durham","year":"2004","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060221","article-title":"Monocentric prospective study into the sustained effect of Incobotulinumtoxin A (XEOMIN\u00ae) botulinum toxin in chronic refractory migraine","volume":"10","author":"Ion","year":"2018","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib95","doi-asserted-by":"crossref","first-page":"378S","DOI":"10.3945\/an.112.003483","article-title":"Magnesium in disease prevention and overall Health","volume":"4","author":"Volpe","year":"2013","journal-title":"Adv Nutr"},{"key":"10.1016\/j.bpa.2020.08.002_bib96","first-page":"912","volume":"vol. 35","author":"Teigen","year":"2015"},{"key":"10.1016\/j.bpa.2020.08.002_bib97","series-title":"StatPearls [Internet]","author":"Allen","year":"2020"},{"key":"10.1016\/j.bpa.2020.08.002_bib98","series-title":"CONTINUUM lifelong learning in neurology","first-page":"796","article-title":"Nonmedication, alternative, and complementary treatments for migraine","volume":"18","author":"Mauskop","year":"2012"},{"key":"10.1016\/j.bpa.2020.08.002_bib99","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s10194-007-0406-7","article-title":"Memantine for prevention of migraine: a retrospective study of 60 cases","volume":"8","author":"Charles","year":"2007","journal-title":"J\u00a0Headache Pain"},{"issue":"9","key":"10.1016\/j.bpa.2020.08.002_bib100","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1526-4610.2008.01083.x","article-title":"Memantine in the preventive treatment of refractory migraine: research submission","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib101","first-page":"788","article-title":"Tolerability and efficacy of memantine as add on therapy in patients with migraine","volume":"16","author":"Assarzadegan","year":"2017","journal-title":"Iran J Pharm Res (IJPR)"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib102","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/head.12732","article-title":"Memantine for prophylactic treatment of migraine without aura: a randomized double-blind placebo-controlled study","volume":"56","author":"Noruzzadeh","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.bpa.2020.08.002_bib103","volume":"vol. 53","author":"Rahbarimanesh","year":"2015"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib104","first-page":"783","article-title":"Comparison of pregabalin and sodium valproate in migraine prophylaxis: a randomized double-blinded study","volume":"17","author":"Hesami","year":"2018","journal-title":"Iran J Pharm Res (IJPR)"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5863\/1551-6776-13.1.17","article-title":"The treatment of migraine headaches in children and adolescents","volume":"13","author":"Brenner","year":"2008","journal-title":"J\u00a0Pediatr Pharmacol Therapeut"},{"key":"10.1016\/j.bpa.2020.08.002_bib106","series-title":"Cephalalgia","first-page":"120","article-title":"Treatment of acute childhood migraine headaches","author":"Linder","year":"1991"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib107","first-page":"223","article-title":"A\u00a0double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis","volume":"48","author":"Rao","year":"2000","journal-title":"Neurol India"},{"key":"10.1016\/j.bpa.2020.08.002_bib108","first-page":"292","volume":"52","author":"Kelley","year":"2012"},{"key":"10.1016\/j.bpa.2020.08.002_bib109","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1468-2982.2006.01191.x","article-title":"Zonisamide for migraine prophylaxis in refractory patients","volume":"26","author":"Ashkenazi","year":"2006","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e318170577f","article-title":"Zonisamide for migraine prophylaxis in Patients refractory to topiramate","volume":"32","author":"Bermejo","year":"2009","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib111","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/WNF.0b013e318225140c","article-title":"Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial","volume":"34","author":"Mohammadianinejad","year":"2011","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.002_bib112","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/epi.12749","article-title":"Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study","volume":"55","author":"Baulac","year":"2014","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib113","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/OPX.0000000000000475","article-title":"Zonisamide-induced angle closure and myopic shift","volume":"92","author":"Weiler","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib114","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WNF.0b013e3182849208","article-title":"Palinopsia induced by topiramate and zonisamide in a patient with migraine","volume":"36","author":"Sierra-Hidalgo","year":"2013","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1526-4610.2001.111006357.x","article-title":"An open-label dose-titration study of the efficacy and tolerability of tizanidine hydrochloride tablets in the prophylaxis of chronic daily headache","volume":"41","author":"Saper","year":"2001","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib116","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1526-4610.2002.02122.x","article-title":"Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study","volume":"42","author":"Saper","year":"2002","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.002_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130733","article-title":"A\u00a0comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache","volume":"10","author":"Jackson","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bpa.2020.08.002_bib118","series-title":"Cochrane database of systematic reviews","article-title":"Feverfew for preventing migraine","volume":"2015","author":"Wider","year":"2015"},{"key":"10.1016\/j.bpa.2020.08.002_bib119","series-title":"Propofol for treatment of acute migraine in the emergency department: a systematic review","author":"Piatka","year":"2020"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-2982.2007.01272.x","article-title":"Occipital nerve stimulation for chronic headache - long-term safety and efficacy","volume":"27","author":"Schwedt","year":"2007","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib121","first-page":"385","article-title":"Use of melatonin versus valproic acid in prophylaxis of migraine patients: a double-blind randomized clinical trial","volume":"35","author":"Ebrahimi-Monfared","year":"2017","journal-title":"Restor Neurol Neurosci"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib122","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults","volume":"4","author":"Banzi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpa.2020.08.002_bib123","article-title":"Migraine headache prophylaxis","author":"Ha","year":"2019","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.bpa.2020.08.002_bib124","volume":"vol. 20","author":"Oskoui","year":"2018"},{"key":"10.1016\/j.bpa.2020.08.002_bib125","series-title":"Neuropsychiatric disease and treatment","first-page":"709","article-title":"Preventive treatment in migraine and the new US guidelines","volume":"9","author":"Estemalik","year":"2013"},{"key":"10.1016\/j.bpa.2020.08.002_bib126","first-page":"1337","volume":"vol. 78","author":"Silberstein","year":"2012"},{"key":"10.1016\/j.bpa.2020.08.002_bib127","series-title":"Report of the quality standards subcommittee of the American Academy of neurology","first-page":"754","article-title":"Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review)","volume":"55","author":"Silberstein","year":"2000"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.002_bib128","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib129","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/head.12055","article-title":"Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II)","volume":"53","author":"Blumenfeld","year":"2013","journal-title":"Headache"},{"key":"10.1016\/j.bpa.2020.08.002_bib130","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-019-0965-4","article-title":"Efficacy of psychological treatment for headache disorder: a systematic review and meta-analysis","volume":"20","author":"Lee","year":"2019","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.bpa.2020.08.002_bib131","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016670","article-title":"Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components","volume":"7","author":"Probyn","year":"2017","journal-title":"BMJ open"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.002_bib132","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0025-7125(05)70359-X","article-title":"Behavioral and nonpharmacologic treatments of headache","volume":"85","author":"Lake","year":"2001","journal-title":"Med Clin North Am"},{"issue":"10203","key":"10.1016\/j.bpa.2020.08.002_bib133","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(19)31946-4","article-title":"Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial","volume":"394","author":"Ferrari","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib134","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12883-018-1193-2","article-title":"A\u00a0phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine","volume":"18","author":"Camporeale","year":"2018","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(17)30083-2","article-title":"Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Tepper","year":"2017","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.002_bib136","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.34.7.973","article-title":"Verapamil in prophylactic therapy of migraine","volume":"34","author":"Markley","year":"1984","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib137","article-title":"Effectiveness of vitamin B2 versus sodium valproate in migraine prophylaxis: a randomized clinical trial","volume":"7","author":"Rahimdel","year":"2015","journal-title":"Electron Physician"},{"issue":"18","key":"10.1016\/j.bpa.2020.08.002_bib138","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.0b013e3181a41269","article-title":"Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs","volume":"72","author":"Di Lorenzo","year":"2009","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib139","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.50.2.466","article-title":"Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial","volume":"50","author":"Schoenen","year":"1998","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.002_bib140","doi-asserted-by":"crossref","first-page":"603","DOI":"10.33588\/rn.3507.2002113","article-title":"Eficacia y seguridad de la gabapentina en el tratamiento preventivo de la migra\u00f1a","volume":"35","author":"Jim\u00e9nez-Hern\u00e1ndez","year":"2002","journal-title":"Rev Neurol"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.002_bib141","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4610.2001.111006119.x","article-title":"Efficacy of gabapentin in migraine prophylaxis","volume":"41","author":"Mathew","year":"2001","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.002_bib142","first-page":"145","article-title":"Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study","volume":"151","author":"Di Trapani","year":"2000","journal-title":"Clin Ter"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.002_bib143","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0333102413515348","article-title":"A\u00a0comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study","volume":"34","author":"Stovner","year":"2014","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib144","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.289.1.65","article-title":"Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial","volume":"289","author":"Tronvik","year":"2003","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.002_bib145","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-019-1030-z","article-title":"Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study","volume":"20","author":"Stark","year":"2019","journal-title":"J\u00a0Headache Pain"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.002_bib146","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.nrl.2016.09.004","article-title":"Experience with botulinum toxin in chronic migraine","volume":"33","author":"Castrillo Sanz","year":"2018","journal-title":"Neurologia"},{"issue":"1\u20133","key":"10.1016\/j.bpa.2020.08.002_bib147","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12011-012-9487-5","article-title":"The effects of magnesium, L-carnitine, and concurrent magnesium-L-carnitine supplementation in migraine prophylaxis","volume":"150","author":"Tarighat Esfanjani","year":"2012","journal-title":"Biol Trace Elem Res"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.002_bib148","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1468-2982.1996.1606436.x","article-title":"Magnesium in the prophylaxis of migraine - a double-blind, placebo-controlled study","volume":"16","author":"Pfaffenrath","year":"1996","journal-title":"Cephalalgia"}],"container-title":["Best Practice & Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:31:46Z","timestamp":1776425506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689620300690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1521689620300690"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2020.08.002","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological options for the treatment of chronic migraine pain","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2020.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}